News – Page 1111 – Endpoints News

Sunovion slammed by FDA rejection of nebulized LAMA for COPD as rival lines up a competing NDA

8 years ago

Ge Li melds WuXi VC with Frontline, creating an $800M trans-Pacific powerhouse fund now hunting fresh biotech capital

8 years ago

Kite catches the inside track on the last leg of a race to the finish line with Novartis on a CAR-T first

8 years ago

As FDA looks to speed reviews even more, 2 policy experts want to restrict the price of drugs that win an accelerated ...

8 years ago

Alexion CEO reboots leadership team; Juno adds former Illumina CEO to its board

8 years ago

Venn and University of Utah partner on immuno-oncology molecule; Biogen losing another exec

8 years ago

Another player drops out of the biosimilars business as shakeout continues

8 years ago

Some worthy initiatives out of the FDA fall far short of an effective federal plan to rein in drug prices

8 years ago

BioCryst gets a big boost from its latest HAE data, but it still faces a dangerous high wire act and giant rivals

8 years ago

FDA experts wave through Pfizer's copycat of an anemia med from Amgen, J&J, but a legal challenge still remains

8 years ago

Scott Gottlieb has some ideas about blocking any more would-be Martin Shkrelis from price gouging

8 years ago

Constellation Pharma recruits its former BD chief to take the helm as CEO

8 years ago

New cardio target ANGPTL3 with promising new studies; Liverpool says Redx is delinquent; Aslan's $33M Taipei IPO

8 years ago

Amgen vet Patrick Baeuerle inspires a $45M round from A-list VCs for a next-gen I/O drug platform

8 years ago

Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau

8 years ago

Mystery biotech Emmaus grabs groundbreaking FDA panel backing for sickle cell drug — after quietly scrapping $225M ...

8 years ago

GW Pharma details an impressive PhIII case for a cannabis-based drug for severe epilepsy as it preps an NDA

8 years ago

Aerie shares shoot up as investigators take another big step to an NDA with 2nd positive glaucoma PhIII

8 years ago

ImmunoGen gets $25M upfront for ADC therapy; miRagen adds European orphan drug designation; Pierre Fabre buys some ...

8 years ago

Puma wins a big round in fight for neratinib OK as experts offer a crucial thumbs up

8 years ago

Novartis swings the ax again, this time aiming at 250 job cuts in the US

8 years ago

The FDA refuses to lift a clinical hold on Cel-Sci’s PhIII drug

8 years ago

Ge Li’s fast-growing WuXi Biologics sets the stage for a $513M IPO

8 years ago

Zai Lab CEO Samantha Du is raising a $150M biotech fund

8 years ago

First page Previous page 1108 1109 111011111112 1113 1114 Next page Last page